Luciana Martins De Carvalho

Dr. Luciana Martins De Carvalho

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
LCLuciana Martins De Carvalho
Luciana Martins De Carvalho
GNGonza Ngoumou
Gonza Ngoumou
JPJi Woo Park
Ji Woo Park
NENadja Ehmke
Nadja Ehmke
NDNikolaus Deigendesch
Nikolaus Deigendesch
YCYanick J. Crow
Yanick J. Crow

25 March 2016 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
RGRoberta C. Gomes
Roberta C. Gomes
MSMarco F. Silva
Marco F. Silva
KKKatia Kozu
Katia Kozu
EBEloisa Bonfá
Eloisa Bonfá
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira
CSClovis A. Silva
Clovis A. Silva
Objective: To evaluate demographic data and clinical and laboratory features at disease diagnosis in 3 different age groups of childhood‐onset systemic lupus erythematosus (SLE): group A, early‐onset (<6 years); group B, school age (≥6 to <12 years); and group C, adolescent (≥12 to <18 years).Methods: This was a Brazilian multicenter cohort retrospective study in 10 pediatric rheumatology centers, including 847 childhood‐onset SLE patients.Results: Patients were divided into 3 groups: group A with 39 patients (4%), group B with 395 patients (47%), and group C with 413 patients (49%). Of 39 childhood‐onset SLE patients in group A, 3 (8%) were ages <2 years, 4 (10%) were ≥2 to <3 years, and 32 (82%) were ≥3 and 0.05). However, the frequency of fever (78% versus 61% versus 47%; P < 0.0001), hepatomegaly (42% versus 29% versus 14%; P < 0.0001), splenomegaly (28% versus 12% versus 4%; P < 0.0001), and discoid lupus (13% versus 4% versus 4%; P = 0.020) was significantly higher in group A compared to groups B and C. The frequency of weight loss >2 kg (19% versus 28% versus 36%; P = 0.017), photosensitivity (34% versus 41% versus 51%; P = 0.006), leukopenia <4,000/mm3 (14% versus 25% versus 30%; P = 0.048), and lymphopenia <1,500/mm3 (22% versus 41% versus 47%; P = 0.011) was significantly lower in group A.Conclusion: Our large multicenter study identified the finding that the initial appearance of childhood‐onset SLE is characterized by comparable high frequency of internal organ involvement and some distinct clinical and laboratory features in early‐onset and adolescent groups.

25 April 2020 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ATAlessandra Tesser
Alessandra Tesser
LCLuciana Martins De Carvalho
Luciana Martins De Carvalho
PSPaula Sandrin-Garcia
Paula Sandrin-Garcia
APAlessia Pin
Alessia Pin
SPSerena Pastore
Serena Pastore
Alberto TommasiniAlberto Tommasini
Alberto Tommasini
Background: Systemic lupus erythematosus (SLE) is a complex multi-system disease, characterized by both autoimmune and autoinflammatory clinical and laboratory features. The role of type I interferon (IFN) in SLE has been demonstrated from the 2000s, by gene expression analyses showing significant over-expression of genes related to type I IFN signalling pathway (IFN signature). However, several studies questioned the role of measuring the intensity of IFN signature (IFN score) to chase SLE activity. We would assess if the IFN signature can help the clinical and therapeutic stratification of patients with pediatric SLE. Methods: We measured the IFN score in peripheral whole blood from a series of subjects with childhood-onset SLE and correlated the results with clinical and laboratory parameters. Results: Thirty-one subjects were included in the study, among which the 87% displayed a positive IFN score. The only significant relation was found for high IFN score in subjects with normocomplementemia. No correlation was observed between IFN score and SLEDAI-2K, BILAG-2004 and SLICC. Patients with high IFN score and normal complement levels also presented lower anti-dsDNA antibodies. Conclusions: The integration between IFN signature analysis and complement levels may easily distinguish two groups of subjects, in which the autoimmune or autoinflammatory component of the disease seems to be prevalent.

7 March 2013 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
LCLuciana Martins De Carvalho
Luciana Martins De Carvalho
FPFlávia E de Paula
Flávia E de Paula
RSRodrigo Vellasco Duarte Silvestre
Rodrigo Vellasco Duarte Silvestre
LRLuciana Rodrigues
Luciana Rodrigues
Eurico ArrudaEurico Arruda
Eurico Arruda
VFVirginia P L Ferriani
Virginia P L Ferriani
Acute respiratory infections (ARI) are frequent in children and complications can occur in patients with chronic diseases. We evaluated the frequency and impact of ARI and influenza-like illness (ILI) episodes on disease activity, and the immunogenicity and safety of influenza vaccine in a cohort of juvenile idiopathic arthritis (JIA) patients.

23 November 2018 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
BGBrazilian Childhood-onset Systemic Lupus Erythematosus Group
Brazilian Childhood-onset Systemic Lupus Erythematosus Group
GBGabriela Blay
Gabriela Blay
JRJoaquim C. Rodrigues
Joaquim C. Rodrigues
JFJuliana C. O. Ferreira
Juliana C. O. Ferreira
GLGabriela N. Leal
Gabriela N. Leal
CSClovis A. Silva
Clovis A. Silva
To evaluate prevalence, clinical manifestations, laboratory abnormalities and treatment in a multicenter cohort study including 847 childhood-onset systemic lupus erythematosus (cSLE) patients with and without diffuse alveolar hemorrhage (DAH), as well as concomitant parameters of severity. DAH was defined as the presence of at least three respiratory symptoms/signs associated with diffuse interstitial/alveolar infiltrates on chest x-ray or high-resolution computer tomography and sudden drop in hemoglobin levels. Statistical analysis was performed using Bonferroni correction (p < 0.0022). DAH was observed in 19/847 (2.2%) cSLE patients. Cough/dyspnea/tachycardia/hypoxemia occurred in all cSLE patients with DAH. Concomitant parameters of severity observed were: mechanical ventilation in 14/19 (74%), hemoptysis 12/19 (63%), macrophage activation syndrome 2/19 (10%) and death 9/19 (47%). Further analysis of cSLE patients at DAH diagnosis compared to 76 cSLE control patients without DAH with same disease duration [3 (1–151) vs. 4 (1–151) months, p = 0.335], showed higher frequencies of constitutional involvement (74% vs. 10%, p < 0.0001), serositis (63% vs. 6%, p < 0.0001) and sepsis (53% vs. 9%, p < 0.0001) in the DAH group. The median of disease activity score(SLEDAI-2 K) was significantly higher in cSLE patients with DAH [18 (5–40) vs. 6 (0–44), p < 0.0001]. The frequencies of thrombocytopenia (53% vs. 12%, p < 0.0001), intravenous methylprednisolone (95% vs. 16%, p < 0.0001) and intravenous cyclophosphamide (47% vs. 8%, p < 0.0001) were also significantly higher in DAH patients. This was the first study to demonstrate that DAH, although not a disease activity score descriptor, occurred in the context of significant moderate/severe cSLE flare. Importantly, we identified that this condition was associated with serious disease flare complicated by sepsis with high mortality rate.

21 November 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
ASAna P. Sakamoto
Ana P. Sakamoto
CSClovis A. Silva
Clovis A. Silva
AIAline G. Islabão
Aline G. Islabão
GNGlaucia V. Novak
Glaucia V. Novak
BMBeatriz Molinari
Beatriz Molinari
FGfor the Brazilian Childhood-onset Systemic Lupus Erythematosus Registry Group
for the Brazilian Childhood-onset Systemic Lupus Erythematosus Registry Group